Shopping Cart 0
Cart Subtotal
USD 0

Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

This report describes and evaluates the global anti-asthmatics and COPD drugs market. It covers two five-year periods, one three-year period, and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2023 forecast period, 2023-2025 forecast period and 2025 -2030 the forecast period.
 
The global anti-asthmatics and COPD drugs market reached a value of nearly USD 40,162.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 4.4% since 2015. The global anti-asthmatics and COPD drugs market is expected to grow from USD 40,162.1 million in 2019 to about USD 49,384.3 million in 2020 due to an increase in demand for the use of anti-asthmatics and COPD drugs in the treatment of Covid-19 patients. The global anti-asthmatics and COPD drugs market is expected to grow at a CAGR of 4.1% to nearly USD 47,176.2 million by 2023. Also the market is expected to growth to USD 51,164.1 million in 2025 at a CAGR of 4.1% and to USD 63,579.9 million in 2030 at a CAGR of 4.4%.
 
Growth in the historic period resulted from increased prevalence of respiratory diseases, increasing incidence of tobacco smoking, global warming, geriatric population, new methods for drug discovery, and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were expiration of patents, and political uncertainties.
 
Going forward, increased popularity of e-cigarettes/vaping, rising obesity levels, technology, large pool of undiagnosed population, use of anti-asthmatics and COPD drugs to treat covid-19 patients, and increasing consumption of fats are expected to drive the market. Factors that could hinder the growth of the anti-asthmatics and COPD drugs market in the future include side effects associated with respiratory drugs, reduction in free trade, and stringent regulations.
 
The anti-asthmatics and COPD drugs market is segmented by type of drug class into combination drugs, bronchodilators, monoclonal antibodies, and anti-inflammatory drugs. The combination drugs market was the largest segment of the anti-asthmatics and COPD drugs market by drug class, accounting for USD 14,964.9 million or 37.3% of the total market in 2019. The monoclonal antibodies market is expected to be the fastest-growing segment going forward at a CAGR of 7.4%.
 
The anti-asthmatics and COPD drugs market is segmented by type of end user into asthma patients, and COPD patients. The asthma patients was the largest segment of the anti-asthmatics and COPD drugs market by end user, accounting for USD 24,791.3 million or 61.7% of the total market in 2019. The COPD patients market is expected to be the fastest-growing segment going forward at a CAGR of 4.5%.
 
The anti-asthmatics and COPD drugs market is segmented by distribution channel into general pharmacies, hospital pharmacies, and online retailers. The general pharmacies was the largest segment of the anti-asthmatics and COPD drugs market by distribution channel, accounting for USD 26,424.3 million or 65.8% of the total market in 2019. The online retailers market is expected to be the fastest-growing segment going forward at a CAGR of 9.6%.
 
The anti-asthmatics and COPD drugs market is segmented by age group into below 5 years, 5 to 14 years, 15-69 years, and 70+ years. The 15-69 years age group was the largest segment of the anti-asthmatics and COPD drugs market by age group, accounting for USD 20,220.7 million or 50.3% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by therapy into preventive, and curative. The preventive was the largest segment of the anti-asthmatics and COPD drugs market by therapy, accounting for USD 21,791.0 million or 54.3% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by route of administration into inhaled, intravenous and subcutaneous, and oral. The inhaled was the largest segment of the anti-asthmatics and COPD drugs market by route of administration, accounting for USD 29,360.8 million or 73.1% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by prescription into prescription, and OTC. The prescription was the largest segment of the anti-asthmatics and COPD drugs market by prescription, accounting for USD 37,521.9 million or 93.4% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by drug type into branded, and generics. The branded was the largest segment of the anti-asthmatics and COPD drugs market by drug type, accounting for USD 38,378.9 million or 95.6% of the total market in 2019.
 
North America was the largest region in the anti-asthmatics and COPD drugs market, accounting for 47.7% of the global market in 2019. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the anti-asthmatics and COPD drugs market will be Asia-Pacific and the Middle East, where growth will be at CAGRs of 8.1% and 5.7% respectively from 2019-2023.
 
The global anti-asthmatics and COPD drugs market is consolidated, with a small number of large players. The top ten competitors in the market made up to 64.6% of the total market in 2019. Major players in the market include GlaxoSmithKline plc., AstraZeneca plc., Boehringer Ingelheim, F. Hoffmann-La Roche Ltd, Novartis and others.
 
COVID-19 is an infectious disease caused by a newly discovered corona virus. COVID-19 which originated in the Wuhan Province of China, in December 2019 has now spread across the world. The unprecedented outbreak of corona virus has caused a surge in demand for anti-asthmatics and COPD drugs as some anti-asthmatics and COPD drugs such as albuterol are being used in the treatment of COVID. With governments across the world advising people to practice social distancing, individuals are stocking up anti-asthmatics and COPD medications, increasing the demand for these drugs.
 
The top growth potential in the anti-asthmatics and COPD drugs market by drug class will arise in combination drugs market, which will gain USD 2,789.8 million of global annual sales by 2023. The top growth potential in the anti-asthmatics and COPD drugs market by end user will arise in the asthma patients market, which will gain USD 4,060.0 million of global annual sales by 2023. The top growth potential in the anti-asthmatics and COPD drugs market by distribution channel will arise in general pharmacies market, which will gain USD 3,593.2 million of global annual sales by 2023. The anti-asthmatics and COPD drugs market size will gain the most in the USA at USD 2,283.6 million. Market-trend-based strategies for the anti-asthmatics and COPD drugs market include focusing on increasing the number of collaborations to expand business portfolios, investing in aerosol respiratory drugs for better efficacy, investing in biomarkers to produce more effective drugs in a smaller time frame, investing in generic drugs to counter the intense competition, developing combination drugs, and developing biologics. Player-adopted strategies in the anti-asthmatics and COPD drugs industry include investing in scientific and technical excellence to develop and launch a pipeline of new products, strengthening anti-asthmatics and COPD drugs business through the expansion of product portfolio, and expanding business through strategic investments focusing on expansion of manufacturing operations.
 
To take advantage of the opportunities, The Business Research Company recommends the anti-asthmatics and COPD drugs companies to focus on personalized medicines, focus on increasing the production temporarily during the COVID-19 pandemic, leverage e-commerce to maximize reach and revenues, provide competitively priced offerings in low-income countries to reach new users, and focus on increasing awareness on asthma and COPD.
READ MORE

Table Of Content

Scope

1. Anti-Asthmatics And COPD Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1.1. Segmentation By Geography

6.1.2. Segmentation By Drug Class

6.1.3. Segmentation By End User

6.1.4. Segmentation By Distribution Channel

6.1.5. Segmentation By Therapy

6.1.6. Segmentation By Route Of Administration

6.1.7. Segmentation By Age Group

6.1.8. Segmentation By Prescription

6.1.9. Segmentation By Drug Type

7. Anti-Asthmatics And COPD Drugs Market Characteristics

7.1. Market Segmentation By Class

7.1.1. Bronchodilators

7.1.2. Anti-Inflammatory Drugs

7.1.3. Monoclonal Antibodies

7.1.4. Combination Drugs

7.2. Market Segmentation By End User

7.2.1. Asthma Patients

7.2.2. COPD Patients

7.3. Market Segmentation By Distribution Channel

7.3.1. Hospital Pharmacies

7.3.2. General Pharmacies

7.3.3. Online Retailers

7.4. Market Segmentation By Therapy

7.4.1. Preventive

7.4.2. Curative

7.5. Market Segmentation By Route Of Administration

7.5.1. Oral

7.5.2. Inhaled

7.5.3. Intravenous

7.5.4. Subcutaneous

7.6. Market Segmentation By Age Group

7.6.1. Below 5

7.6.2. 5-14

7.6.3. 15-60

7.6.4. Above 60

7.7. Market Segmentation By Prescription

7.7.1. Prescription

7.7.2. Over The Counter (OTC)

7.8. Market Segmentation By Drug Type

7.8.1. Branded

7.8.2. Generic

8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis

8.1.1. Raw Material And Equipment Procurement

8.1.2. Manufacturing, Processing and Packaging

8.1.3. Distribution

8.1.4. Physicians

8.1.5. End users

9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales

10.1.1. Ellipta

10.1.2. Spiriva

10.1.3. Symbicort

10.1.4. Advair

10.1.5. Pulmicort

10.1.6. Ventolin

10.1.7. Xolair

10.1.8. Nucala

10.1.9. Flovent

10.1.10. Fasenra

11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs

11.1.1. Background

11.1.2. Innovators

12. Anti-Asthmatics And COPD Drugs Market, Customer Information

12.1. Majority Of Australian COPD Patients Are Physically Inactive And Obese

12.2. Britons Experience Inadequate Treatment Of COPD

12.3. COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers

12.4. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits

12.5. Uncontrolled Asthma Patients Struggle With Mobility Issues

13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market

13.1. Consumer Perception

13.2. High Mortality Among Asthma Patients

13.3. Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment

14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

14.1.1. India

14.1.2. China

14.1.3. Japan

14.1.4. Australia

14.1.5. South Korea

14.1.6. Indonesia

14.1.7. USA

14.1.8. Canada

14.1.9. Mexico

14.1.10. UK

14.1.11. Germany

14.1.12. France

14.1.13. Russia

14.1.14. Brazil

15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies

15.1. Collaborations In The Anti-Asthmatics and COPD Drugs Market

15.2. Increasing Demand For Personalized Medicines

15.3. Demand For Aerosol Respiratory Drugs

15.4. Use Of Biomarker For Precision Medicine

15.5. Rise Of Generic Respiratory Drugs

15.6. Combination Drug Therapy To Treat COPD

15.7.New Biologic Therapy Medicines To Treat Severe Asthma

16. Asthma And COPD Prevalence Overview

16.1. Asthma

16.2. COPD

17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth

17.1. Market Size

17.2. Historic Market Growth, 2015-2019, Value (USD Million)

17.2.1. Historic Drivers Of The Market 2015-2019

17.2.2. Historic Restraints Of The Market 2015-2019

17.3. Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

17.3.1. Forecast Drivers Of The Market 2019-2023

17.3.2. Forecast Restraints Of The Market 2019-2023

18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis

18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19. Global Anti-Asthmatics And COPD Drugs Market Segmentation

19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19.1.1. Combination Drugs

19.1.2. Bronchodilators

19.1.3. Monoclonal Antibodies

19.1.4. Anti-Inflammatory Drugs

19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19.2.1. Asthma Patients

19.2.2. COPD Patients

19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19.3.1. General Pharmacies

19.3.2. Hospital Pharmacies

19.3.3. Online Retailers

19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019, Value (USD Million)

19.4.1. Preventive

19.4.2. Curative

19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019, Value (USD Million)

19.5.1. Inhaled

19.5.2. Intravenous and Subcutaneous

19.5.3. Oral

19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019, Value (USD Million)

19.6.1. 15-69 Years

19.6.2. 70+ Years

19.6.3. Below 5 Years

19.7. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019, Value (USD Million)

19.7.1. Prescription

19.7.2. OTC

19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019, Value (USD Million)

19.8.1. Branded

19.8.2. Generics

20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market

20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview

20.1.1. Region Information

20.1.2. Market Information

20.1.3. Background Information

20.1.4. Government Initiatives

20.1.5. New Drug Trials And Approvals

20.1.6. Major Associations

20.1.7. Taxes Levied

20.1.8. Investments

20.1.9. Major Companies

20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis

20.7. China Anti-Asthmatics And COPD Drugs Market

20.8. China Anti-Asthmatics And COPD Drugs Market Overview

20.8.1. Country Information

20.8.2. Market Information

20.8.3. Background Information

20.8.4. Government Initiatives

20.8.5. New Drug Trials And Approvals

20.8.6. Major Associations

20.8.7. Taxes Levied

20.8.8. Investments

20.8.9. Major Companies

20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.13. India Anti-Asthmatics And COPD Drugs Market

20.14. India Anti-Asthmatics And COPD Drugs Market Overview

20.14.1. Country Information

20.14.2. Market Information

20.14.3. Background Information

20.14.4. Government Initiatives

20.14.5. Major Associations

20.14.6. Taxes Levied

20.14.7. Investments

20.14.8. Major Companies

20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.19. Japan Anti-Asthmatics And COPD Drugs Market

20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview

20.20.1. Country Information

20.20.2. Market Information

20.20.3. Background Information

20.20.4. Government Initiatives

20.20.5. New Drug Trials And Approvals

20.20.6. Major Associations

20.20.7. Taxes Levied

20.20.8. Investments

20.20.9. Major Companies

20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.25. Australia Anti-Asthmatics And COPD Drugs Market

20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.30. Indonesia Anti-Asthmatics And COPD Drugs Market

20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.35. South Korea Anti-Asthmatics And COPD Drugs Market

20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21. Western Europe Anti-Asthmatics And COPD Drugs Market

21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview

21.1.1. Region Information

21.1.2. Market Information

21.1.3. Background Information

21.1.4. Government Initiatives

21.1.5. New Drug Trials And Approvals

21.1.6. Major Associations

21.1.7. Taxes Levied

21.1.8. Major Companies

21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis

21.7. UK Anti-Asthmatics And COPD Drugs Market

21.8. UK Anti-Asthmatics And COPD Drugs Market Overview

21.8.1. Country Information

21.8.2. Market Information

21.8.3. Background Information

21.8.4. Government Initiatives

21.8.5. New Drug Trials And Approvals

21.8.6. Major Associations

21.8.7. Taxes Levied

21.8.8. Major Companies

21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.13. Germany Anti-Asthmatics And COPD Drugs Market

21.14. Germany Anti-Asthmatics And COPD Drugs, Historic Market Growth, 2015-2019, Value (USD Million)

21.15. Germany Anti-Asthmatics And COPD Drugs, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.18. France Anti-Asthmatics And COPD Drugs Market

21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22. Eastern Europe Anti-Asthmatics And COPD Drugs Market

22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview

22.1.1. Region Information

22.1.2. Market Information

22.1.3. Background Information

22.1.4. New Drug Trials And Approvals

22.1.5. Major Associations

22.1.6. Taxes Levied

22.1.7. Major Companies

22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22.6. Russia Anti-Asthmatics And COPD Drugs Market

22.7. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

22.8. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

22.9. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23. North America Anti-Asthmatics And COPD Drugs Market

23.1. North America Anti-Asthmatics And COPD Drugs Market Overview

23.1.1. Region Information

23.1.2. Market Information

23.1.3. Background Information

23.1.4. Government Initiatives

23.1.5. New Drug Trials And Approvals

23.1.6. Major Associations

23.1.7. Taxes Levied

23.1.8. Investments

23.1.9. Major Companies

23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis

23.7. USA Anti-Asthmatics And COPD Drugs Market

23.8. USA Anti-Asthmatics And COPD Drugs Market Overview

23.8.1. Country Information

23.8.2. Market Information

23.8.3. Background Information

23.8.4. Government Initiatives

23.8.5. Major Associations

23.8.6. Taxes Levied

23.8.7. Investments

23.8.8. Major Companies

23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24. South America Anti-Asthmatics And COPD Drugs Market

24.1. South America Anti-Asthmatics And COPD Drugs Market Overview

24.1.1. Region Information

24.1.2. Market Information

24.1.3. Background Information

24.1.4. Major Associations

24.1.5. Government Initiatives

24.1.6. Investments

24.1.7. Major Companies

24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis

24.7. Brazil Anti-Asthmatics And COPD Drugs Market

24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

25. Middle East Anti-Asthmatics And COPD Drugs Market

25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview

25.1.1. Region Information

25.1.2. Market Information

25.1.3. Background Information

25.1.4. Government Initiatives

25.1.5. Major Associations

25.1.6. Taxes Levied

25.1.7. Major Companies

25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

26. Africa Anti-Asthmatics And COPD Drugs Market

26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview

26.1.1. Region Information

26.1.2. Market Information

26.1.3. Background Information

26.1.4. Government Initiatives

26.1.5. Major Associations

26.1.6. Taxes Levied

26.1.7. Investments

26.1.8. Major Companies

26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape

27.1. Company Profiles

27.2. GlaxoSmithKline plc.

27.2.1. Company Overview

27.2.2. Products And Services

27.2.3. Business Strategy

27.2.4. Financial Overview

27.3. AstraZeneca plc.

27.3.1. Company Overview

27.3.2. Products And Services

27.3.3. Business Strategy

27.3.4. Financial Overview

27.4. Boehringer-Ingelheim GmbH

27.4.1. Company Overview

27.4.2. Products And Services

27.4.3. Business Strategy

27.4.4. Financial Overview

27.5. F. Hoffmann-La Roche Ltd

27.5.1. Company Overview

27.5.2. Products And Services

27.5.3. Business Strategy

27.5.4. Financial Overview

27.6. Novartis AG

27.6.1. Company Overview

27.6.2. Products And Services

27.6.3. Business Strategy

27.6.4. Financial Overview

28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market

28.1. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical

28.2. ResMed Acquired Propeller Health

28.3. Circassia Acquired AstraZeneca's COPD Treatment Tudorza

28.4. RecipharmAB Acquired Sanofi's Inhalation Contract Manufacturing Business

28.5. Mast Therapeutics, Inc. Merged With Savara Inc.

28.6. Mylan N.V. Acquired Majority Stake In Meda AB

28.7. Vectura Group Merged With Skyepharma

28.8. Recordati Acquired Italchimici S.p.A.

28.9. Ruthigen, Inc. Merged With Pulmatrix, Inc.

29. Market Background: Respiratory Diseases Drugs Market

29.1. Respiratory Diseases Drugs Market Characteristics

29.1.1. Market Definition

29.1.2. Segmentation By Type

29.1.3. Anti-Asthmatics And COPD Drugs

29.1.4. Cough And Cold Preparations

29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2023, Value (USD Billion)

29.3. Global Respiratory Diseases Drugs Market, 2019, By Region, Value (USD Billion)

29.4. Global Respiratory Diseases Drugs Market, 2015-2023, Historic And Forecast, By Region

30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies

30.1. Global Anti-Asthmatics And COPD Drugs Market In 2023-Countries Offering Most New Opportunities

30.2. Global Anti-Asthmatics And COPD Drugs Market In 2023- Segments Offering Most New Opportunities

30.3. Global Anti-Asthmatics And COPD Drugs Market In 2023-Growth Strategies

30.3.1. Market Trend Based Strategies

30.3.2. Competitor Strategies

31. Global Anti-Asthmatics And COPD Drugs Market Recommendations

31.1. Conclusions

31.2. Recommendations

31.2.1. Product

31.2.2. Place

31.2.3. Price

31.2.4. Promotion

32. Appendix

32.1. Market Data Sources

32.2. Research Methodology

32.3. Currencies

32.4. Research Inquiries

32.5. The Business Research Company

32.6. Copyright and Disclaimer


List Of Figure

Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class

Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User

Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel

Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy

Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration

Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group

Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription

Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type

Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs

Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019

Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019

Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019

Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019

Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019

Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)

Figure 99: GlaxoSmithKline-Financial Performance, 2015-2019, USD Billion

Figure 100: AstraZeneca plc.-Financial Performance2015-2019, USD Billion

Figure 101: Boehringer Ingelheim GmbH-Financial Performance, 2015-2019, USD Billion

Figure 102: F. Hoffmann-La Roche Ltd-Financial Performance, 2015-2019, USD Billion

Figure 103: Novartis AG-Financial Performance, 2015-2019, USD Billion

Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2023, USD Billion

Figure 105: Global Respiratory Diseases Drugs Market, 2019, Split By Region

Figure 106: Global Respiratory Diseases Drugs Market, 2015-2023, Historic And Forecast Growth Rate, Split By Region


List Of Table

Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2019

Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2019

Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

Table 5: Prevalence Of Asthma, 2014-2017

Table 6: Prevalence Of COPD, 2014-2017

Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019

Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019

Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019

Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019

Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019

Table 24: Asia-Pacific Public Healthcare Expenditure, 2015-2019, USD Billion

Table 25: Asia-Pacific Private Healthcare Expenditure, 2015-2019, USD Billion

Table 26: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands

Table 27: Air Pollution And Air Quality Index, Asia-Pacific Countries

Table 28: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 29: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 30: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 31: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 34: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 35: China Total Population Aged 65 And Above, 2015-2023, Thousands

Table 36: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 37: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 38: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 39: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 40: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 41: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 42: India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 43: India Total Population Aged 65 And Above, 2015-2023, Thousands

Table 44: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 45: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 46: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 47: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 48: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 49: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 50: Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 51: Japan Total Population Aged 65 And Above, 2015-2023, Thousands

Table 52: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 53: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 54: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 55: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 56: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 57: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 58: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 59: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 60: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 61: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 62: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 63: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 64: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 65: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 66: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 67: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 68: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 69: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 70: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 71: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 72: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 73: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 74: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 75: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 76: Western Europe Public Healthcare Expenditure, 2015-2019, USD Billion

Table 77: Western Europe Private Healthcare Expenditure, 2015-2019, USD Billion

Table 78: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands

Table 79: Air Pollution And Air Quality Index in 2018, Western Europe Countries

Table 80: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 81: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 82: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 83: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 84: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 85: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 86: UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 87: UK Total Population Aged 65 And Above, 2015-2023, Thousands

Table 88: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 89: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 90: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 91: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 92: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 93: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 94: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 95: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 96: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 97: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 98: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 99: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 100: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 101: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 102: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 103: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 104: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 105: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 106: Eastern Europe Public Healthcare Expenditure, 2015-2019, USD Billion

Table 107: Eastern Europe Private Healthcare Expenditure, 2015-2019, USD Billion

Table 108: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands

Table 109: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 110: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 111: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 112: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 113: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 114: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 115: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 116: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 117: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 118: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 119: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 120: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 121: North America Public Healthcare Expenditure, 2015-2019, USD Billion

Table 122: North America Private Healthcare Expenditure, 2013-2017, USD Billion

Table 123: North America Total Population Aged 65 And Above, 2015-2023, Thousands

Table 124: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 125: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 126: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 127: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 128: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 129: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 130: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 131: USA Total Population Aged 65 And Above, 2015-2023, Thousands

Table 132: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 133: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 134: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 135: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 136: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 137: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 138: South America Public Healthcare Expenditure, 2015-2019, USD Billion

Table 139: South America Private Healthcare Expenditure, 2015-2019, USD Billion

Table 140: South America Total Population Aged 65 And Above, 2015-2023, Thousands

Table 141: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 142: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 143: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 144: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 145: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 146: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 147: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 148: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 149: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 150: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 151: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 152: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 153: Middle East Public Healthcare Expenditure, 2015-2019, USD Billion

Table 154: Middle East Private Healthcare Expenditure, 2015-2019, USD Billion

Table 155: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands

Table 156: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 157: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 158: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 159: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 160: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 161: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 162: Africa Public Healthcare Expenditure, 2015-2019, USD Billion

Table 163: Africa Private Healthcare Expenditure, 2015-2019, USD Billion

Table 164: Africa Total Population Aged 65 And Above, 2015-2023, Thousands

Table 165: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 166: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 167: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 168: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 169: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 170: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 171: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)

Table 172: GlaxoSmithKline-Financial Performance, 2015-2019, USD Billion

Table 173: AstraZeneca plc.-Financial Performance2015-2019, USD Billion

Table 174: Boehringer Ingelheim GmbH-Financial Performance, 2015-2019, USD Billion

Table 175: F. Hoffmann-La Roche Ltd.-Financial Performance, 2015-2019, USD Billion

Table 176: Novartis AG-Financial Performance, 2015-2019, USD Billion

Table 177: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2023, USD Billion

Table 178: Global Respiratory Diseases Drugs Market, 2019, Split By Region

Table 179: Global Respiratory Diseases Drugs Market, 2015-2023, Historic And Forecast Growth Rate, Split By Region

Table 180: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, By Country

Table 181: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, Segmentation By Drug Class

Table 182: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, By Type Of End User

Table 183: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, By Distribution Channel

Table 184: Anti-Asthmatics And COPD Drugs Market Data Sources

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

By Type Of Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs By Type Of End-User: Asthma Patients; COPD Patients By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers By Age Group: Below 5 Years; 5 to 14 Years; 15-69 Years; 70+ Years By Type Of Therapy: Preventive; Curative By Route Of Administration: Inhaled; Intravenous and Subcutaneous; Oral By Type Of Prescription: Prescription; OTC By Type Of Drug: Branded; Generics


Companies

GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer Ingelheim; F. Hoffmann-La Roche Ltd; Novartis

Company Profile

Company Profile Title

This report describes and evaluates the global anti-asthmatics and COPD drugs market. It covers two five-year periods, one three-year period, and one six-year period including, 2015 to 2019, termed the historic period, and 2019 to 2023 forecast period, 2023-2025 forecast period and 2025 -2030 the forecast period.
 
The global anti-asthmatics and COPD drugs market reached a value of nearly USD 40,162.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 4.4% since 2015. The global anti-asthmatics and COPD drugs market is expected to grow from USD 40,162.1 million in 2019 to about USD 49,384.3 million in 2020 due to an increase in demand for the use of anti-asthmatics and COPD drugs in the treatment of Covid-19 patients. The global anti-asthmatics and COPD drugs market is expected to grow at a CAGR of 4.1% to nearly USD 47,176.2 million by 2023. Also the market is expected to growth to USD 51,164.1 million in 2025 at a CAGR of 4.1% and to USD 63,579.9 million in 2030 at a CAGR of 4.4%.
 
Growth in the historic period resulted from increased prevalence of respiratory diseases, increasing incidence of tobacco smoking, global warming, geriatric population, new methods for drug discovery, and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were expiration of patents, and political uncertainties.
 
Going forward, increased popularity of e-cigarettes/vaping, rising obesity levels, technology, large pool of undiagnosed population, use of anti-asthmatics and COPD drugs to treat covid-19 patients, and increasing consumption of fats are expected to drive the market. Factors that could hinder the growth of the anti-asthmatics and COPD drugs market in the future include side effects associated with respiratory drugs, reduction in free trade, and stringent regulations.
 
The anti-asthmatics and COPD drugs market is segmented by type of drug class into combination drugs, bronchodilators, monoclonal antibodies, and anti-inflammatory drugs. The combination drugs market was the largest segment of the anti-asthmatics and COPD drugs market by drug class, accounting for USD 14,964.9 million or 37.3% of the total market in 2019. The monoclonal antibodies market is expected to be the fastest-growing segment going forward at a CAGR of 7.4%.
 
The anti-asthmatics and COPD drugs market is segmented by type of end user into asthma patients, and COPD patients. The asthma patients was the largest segment of the anti-asthmatics and COPD drugs market by end user, accounting for USD 24,791.3 million or 61.7% of the total market in 2019. The COPD patients market is expected to be the fastest-growing segment going forward at a CAGR of 4.5%.
 
The anti-asthmatics and COPD drugs market is segmented by distribution channel into general pharmacies, hospital pharmacies, and online retailers. The general pharmacies was the largest segment of the anti-asthmatics and COPD drugs market by distribution channel, accounting for USD 26,424.3 million or 65.8% of the total market in 2019. The online retailers market is expected to be the fastest-growing segment going forward at a CAGR of 9.6%.
 
The anti-asthmatics and COPD drugs market is segmented by age group into below 5 years, 5 to 14 years, 15-69 years, and 70+ years. The 15-69 years age group was the largest segment of the anti-asthmatics and COPD drugs market by age group, accounting for USD 20,220.7 million or 50.3% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by therapy into preventive, and curative. The preventive was the largest segment of the anti-asthmatics and COPD drugs market by therapy, accounting for USD 21,791.0 million or 54.3% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by route of administration into inhaled, intravenous and subcutaneous, and oral. The inhaled was the largest segment of the anti-asthmatics and COPD drugs market by route of administration, accounting for USD 29,360.8 million or 73.1% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by prescription into prescription, and OTC. The prescription was the largest segment of the anti-asthmatics and COPD drugs market by prescription, accounting for USD 37,521.9 million or 93.4% of the total market in 2019.
 
The anti-asthmatics and COPD drugs market is segmented by drug type into branded, and generics. The branded was the largest segment of the anti-asthmatics and COPD drugs market by drug type, accounting for USD 38,378.9 million or 95.6% of the total market in 2019.
 
North America was the largest region in the anti-asthmatics and COPD drugs market, accounting for 47.7% of the global market in 2019. It was followed by Asia Pacific, Western Europe and the other regions. Going forward, the fastest growing regions in the anti-asthmatics and COPD drugs market will be Asia-Pacific and the Middle East, where growth will be at CAGRs of 8.1% and 5.7% respectively from 2019-2023.
 
The global anti-asthmatics and COPD drugs market is consolidated, with a small number of large players. The top ten competitors in the market made up to 64.6% of the total market in 2019. Major players in the market include GlaxoSmithKline plc., AstraZeneca plc., Boehringer Ingelheim, F. Hoffmann-La Roche Ltd, Novartis and others.
 
COVID-19 is an infectious disease caused by a newly discovered corona virus. COVID-19 which originated in the Wuhan Province of China, in December 2019 has now spread across the world. The unprecedented outbreak of corona virus has caused a surge in demand for anti-asthmatics and COPD drugs as some anti-asthmatics and COPD drugs such as albuterol are being used in the treatment of COVID. With governments across the world advising people to practice social distancing, individuals are stocking up anti-asthmatics and COPD medications, increasing the demand for these drugs.
 
The top growth potential in the anti-asthmatics and COPD drugs market by drug class will arise in combination drugs market, which will gain USD 2,789.8 million of global annual sales by 2023. The top growth potential in the anti-asthmatics and COPD drugs market by end user will arise in the asthma patients market, which will gain USD 4,060.0 million of global annual sales by 2023. The top growth potential in the anti-asthmatics and COPD drugs market by distribution channel will arise in general pharmacies market, which will gain USD 3,593.2 million of global annual sales by 2023. The anti-asthmatics and COPD drugs market size will gain the most in the USA at USD 2,283.6 million. Market-trend-based strategies for the anti-asthmatics and COPD drugs market include focusing on increasing the number of collaborations to expand business portfolios, investing in aerosol respiratory drugs for better efficacy, investing in biomarkers to produce more effective drugs in a smaller time frame, investing in generic drugs to counter the intense competition, developing combination drugs, and developing biologics. Player-adopted strategies in the anti-asthmatics and COPD drugs industry include investing in scientific and technical excellence to develop and launch a pipeline of new products, strengthening anti-asthmatics and COPD drugs business through the expansion of product portfolio, and expanding business through strategic investments focusing on expansion of manufacturing operations.
 
To take advantage of the opportunities, The Business Research Company recommends the anti-asthmatics and COPD drugs companies to focus on personalized medicines, focus on increasing the production temporarily during the COVID-19 pandemic, leverage e-commerce to maximize reach and revenues, provide competitively priced offerings in low-income countries to reach new users, and focus on increasing awareness on asthma and COPD.
READ MORE

Scope

1. Anti-Asthmatics And COPD Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1.1. Segmentation By Geography

6.1.2. Segmentation By Drug Class

6.1.3. Segmentation By End User

6.1.4. Segmentation By Distribution Channel

6.1.5. Segmentation By Therapy

6.1.6. Segmentation By Route Of Administration

6.1.7. Segmentation By Age Group

6.1.8. Segmentation By Prescription

6.1.9. Segmentation By Drug Type

7. Anti-Asthmatics And COPD Drugs Market Characteristics

7.1. Market Segmentation By Class

7.1.1. Bronchodilators

7.1.2. Anti-Inflammatory Drugs

7.1.3. Monoclonal Antibodies

7.1.4. Combination Drugs

7.2. Market Segmentation By End User

7.2.1. Asthma Patients

7.2.2. COPD Patients

7.3. Market Segmentation By Distribution Channel

7.3.1. Hospital Pharmacies

7.3.2. General Pharmacies

7.3.3. Online Retailers

7.4. Market Segmentation By Therapy

7.4.1. Preventive

7.4.2. Curative

7.5. Market Segmentation By Route Of Administration

7.5.1. Oral

7.5.2. Inhaled

7.5.3. Intravenous

7.5.4. Subcutaneous

7.6. Market Segmentation By Age Group

7.6.1. Below 5

7.6.2. 5-14

7.6.3. 15-60

7.6.4. Above 60

7.7. Market Segmentation By Prescription

7.7.1. Prescription

7.7.2. Over The Counter (OTC)

7.8. Market Segmentation By Drug Type

7.8.1. Branded

7.8.2. Generic

8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis

8.1.1. Raw Material And Equipment Procurement

8.1.2. Manufacturing, Processing and Packaging

8.1.3. Distribution

8.1.4. Physicians

8.1.5. End users

9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales

10.1.1. Ellipta

10.1.2. Spiriva

10.1.3. Symbicort

10.1.4. Advair

10.1.5. Pulmicort

10.1.6. Ventolin

10.1.7. Xolair

10.1.8. Nucala

10.1.9. Flovent

10.1.10. Fasenra

11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs

11.1.1. Background

11.1.2. Innovators

12. Anti-Asthmatics And COPD Drugs Market, Customer Information

12.1. Majority Of Australian COPD Patients Are Physically Inactive And Obese

12.2. Britons Experience Inadequate Treatment Of COPD

12.3. COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers

12.4. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits

12.5. Uncontrolled Asthma Patients Struggle With Mobility Issues

13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market

13.1. Consumer Perception

13.2. High Mortality Among Asthma Patients

13.3. Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment

14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

14.1.1. India

14.1.2. China

14.1.3. Japan

14.1.4. Australia

14.1.5. South Korea

14.1.6. Indonesia

14.1.7. USA

14.1.8. Canada

14.1.9. Mexico

14.1.10. UK

14.1.11. Germany

14.1.12. France

14.1.13. Russia

14.1.14. Brazil

15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies

15.1. Collaborations In The Anti-Asthmatics and COPD Drugs Market

15.2. Increasing Demand For Personalized Medicines

15.3. Demand For Aerosol Respiratory Drugs

15.4. Use Of Biomarker For Precision Medicine

15.5. Rise Of Generic Respiratory Drugs

15.6. Combination Drug Therapy To Treat COPD

15.7.New Biologic Therapy Medicines To Treat Severe Asthma

16. Asthma And COPD Prevalence Overview

16.1. Asthma

16.2. COPD

17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth

17.1. Market Size

17.2. Historic Market Growth, 2015-2019, Value (USD Million)

17.2.1. Historic Drivers Of The Market 2015-2019

17.2.2. Historic Restraints Of The Market 2015-2019

17.3. Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

17.3.1. Forecast Drivers Of The Market 2019-2023

17.3.2. Forecast Restraints Of The Market 2019-2023

18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis

18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19. Global Anti-Asthmatics And COPD Drugs Market Segmentation

19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19.1.1. Combination Drugs

19.1.2. Bronchodilators

19.1.3. Monoclonal Antibodies

19.1.4. Anti-Inflammatory Drugs

19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19.2.1. Asthma Patients

19.2.2. COPD Patients

19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

19.3.1. General Pharmacies

19.3.2. Hospital Pharmacies

19.3.3. Online Retailers

19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019, Value (USD Million)

19.4.1. Preventive

19.4.2. Curative

19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019, Value (USD Million)

19.5.1. Inhaled

19.5.2. Intravenous and Subcutaneous

19.5.3. Oral

19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019, Value (USD Million)

19.6.1. 15-69 Years

19.6.2. 70+ Years

19.6.3. Below 5 Years

19.7. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019, Value (USD Million)

19.7.1. Prescription

19.7.2. OTC

19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019, Value (USD Million)

19.8.1. Branded

19.8.2. Generics

20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market

20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview

20.1.1. Region Information

20.1.2. Market Information

20.1.3. Background Information

20.1.4. Government Initiatives

20.1.5. New Drug Trials And Approvals

20.1.6. Major Associations

20.1.7. Taxes Levied

20.1.8. Investments

20.1.9. Major Companies

20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis

20.7. China Anti-Asthmatics And COPD Drugs Market

20.8. China Anti-Asthmatics And COPD Drugs Market Overview

20.8.1. Country Information

20.8.2. Market Information

20.8.3. Background Information

20.8.4. Government Initiatives

20.8.5. New Drug Trials And Approvals

20.8.6. Major Associations

20.8.7. Taxes Levied

20.8.8. Investments

20.8.9. Major Companies

20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.13. India Anti-Asthmatics And COPD Drugs Market

20.14. India Anti-Asthmatics And COPD Drugs Market Overview

20.14.1. Country Information

20.14.2. Market Information

20.14.3. Background Information

20.14.4. Government Initiatives

20.14.5. Major Associations

20.14.6. Taxes Levied

20.14.7. Investments

20.14.8. Major Companies

20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.19. Japan Anti-Asthmatics And COPD Drugs Market

20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview

20.20.1. Country Information

20.20.2. Market Information

20.20.3. Background Information

20.20.4. Government Initiatives

20.20.5. New Drug Trials And Approvals

20.20.6. Major Associations

20.20.7. Taxes Levied

20.20.8. Investments

20.20.9. Major Companies

20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.25. Australia Anti-Asthmatics And COPD Drugs Market

20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.30. Indonesia Anti-Asthmatics And COPD Drugs Market

20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.35. South Korea Anti-Asthmatics And COPD Drugs Market

20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21. Western Europe Anti-Asthmatics And COPD Drugs Market

21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview

21.1.1. Region Information

21.1.2. Market Information

21.1.3. Background Information

21.1.4. Government Initiatives

21.1.5. New Drug Trials And Approvals

21.1.6. Major Associations

21.1.7. Taxes Levied

21.1.8. Major Companies

21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis

21.7. UK Anti-Asthmatics And COPD Drugs Market

21.8. UK Anti-Asthmatics And COPD Drugs Market Overview

21.8.1. Country Information

21.8.2. Market Information

21.8.3. Background Information

21.8.4. Government Initiatives

21.8.5. New Drug Trials And Approvals

21.8.6. Major Associations

21.8.7. Taxes Levied

21.8.8. Major Companies

21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.13. Germany Anti-Asthmatics And COPD Drugs Market

21.14. Germany Anti-Asthmatics And COPD Drugs, Historic Market Growth, 2015-2019, Value (USD Million)

21.15. Germany Anti-Asthmatics And COPD Drugs, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.18. France Anti-Asthmatics And COPD Drugs Market

21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22. Eastern Europe Anti-Asthmatics And COPD Drugs Market

22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview

22.1.1. Region Information

22.1.2. Market Information

22.1.3. Background Information

22.1.4. New Drug Trials And Approvals

22.1.5. Major Associations

22.1.6. Taxes Levied

22.1.7. Major Companies

22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22.6. Russia Anti-Asthmatics And COPD Drugs Market

22.7. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

22.8. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

22.9. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23. North America Anti-Asthmatics And COPD Drugs Market

23.1. North America Anti-Asthmatics And COPD Drugs Market Overview

23.1.1. Region Information

23.1.2. Market Information

23.1.3. Background Information

23.1.4. Government Initiatives

23.1.5. New Drug Trials And Approvals

23.1.6. Major Associations

23.1.7. Taxes Levied

23.1.8. Investments

23.1.9. Major Companies

23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis

23.7. USA Anti-Asthmatics And COPD Drugs Market

23.8. USA Anti-Asthmatics And COPD Drugs Market Overview

23.8.1. Country Information

23.8.2. Market Information

23.8.3. Background Information

23.8.4. Government Initiatives

23.8.5. Major Associations

23.8.6. Taxes Levied

23.8.7. Investments

23.8.8. Major Companies

23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24. South America Anti-Asthmatics And COPD Drugs Market

24.1. South America Anti-Asthmatics And COPD Drugs Market Overview

24.1.1. Region Information

24.1.2. Market Information

24.1.3. Background Information

24.1.4. Major Associations

24.1.5. Government Initiatives

24.1.6. Investments

24.1.7. Major Companies

24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis

24.7. Brazil Anti-Asthmatics And COPD Drugs Market

24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

25. Middle East Anti-Asthmatics And COPD Drugs Market

25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview

25.1.1. Region Information

25.1.2. Market Information

25.1.3. Background Information

25.1.4. Government Initiatives

25.1.5. Major Associations

25.1.6. Taxes Levied

25.1.7. Major Companies

25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

26. Africa Anti-Asthmatics And COPD Drugs Market

26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview

26.1.1. Region Information

26.1.2. Market Information

26.1.3. Background Information

26.1.4. Government Initiatives

26.1.5. Major Associations

26.1.6. Taxes Levied

26.1.7. Investments

26.1.8. Major Companies

26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015-2019, Value (USD Million)

26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2019-2023, 2025F, 2030F Value (USD Million)

26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value (USD Million)

27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape

27.1. Company Profiles

27.2. GlaxoSmithKline plc.

27.2.1. Company Overview

27.2.2. Products And Services

27.2.3. Business Strategy

27.2.4. Financial Overview

27.3. AstraZeneca plc.

27.3.1. Company Overview

27.3.2. Products And Services

27.3.3. Business Strategy

27.3.4. Financial Overview

27.4. Boehringer-Ingelheim GmbH

27.4.1. Company Overview

27.4.2. Products And Services

27.4.3. Business Strategy

27.4.4. Financial Overview

27.5. F. Hoffmann-La Roche Ltd

27.5.1. Company Overview

27.5.2. Products And Services

27.5.3. Business Strategy

27.5.4. Financial Overview

27.6. Novartis AG

27.6.1. Company Overview

27.6.2. Products And Services

27.6.3. Business Strategy

27.6.4. Financial Overview

28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market

28.1. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical

28.2. ResMed Acquired Propeller Health

28.3. Circassia Acquired AstraZeneca's COPD Treatment Tudorza

28.4. RecipharmAB Acquired Sanofi's Inhalation Contract Manufacturing Business

28.5. Mast Therapeutics, Inc. Merged With Savara Inc.

28.6. Mylan N.V. Acquired Majority Stake In Meda AB

28.7. Vectura Group Merged With Skyepharma

28.8. Recordati Acquired Italchimici S.p.A.

28.9. Ruthigen, Inc. Merged With Pulmatrix, Inc.

29. Market Background: Respiratory Diseases Drugs Market

29.1. Respiratory Diseases Drugs Market Characteristics

29.1.1. Market Definition

29.1.2. Segmentation By Type

29.1.3. Anti-Asthmatics And COPD Drugs

29.1.4. Cough And Cold Preparations

29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2023, Value (USD Billion)

29.3. Global Respiratory Diseases Drugs Market, 2019, By Region, Value (USD Billion)

29.4. Global Respiratory Diseases Drugs Market, 2015-2023, Historic And Forecast, By Region

30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies

30.1. Global Anti-Asthmatics And COPD Drugs Market In 2023-Countries Offering Most New Opportunities

30.2. Global Anti-Asthmatics And COPD Drugs Market In 2023- Segments Offering Most New Opportunities

30.3. Global Anti-Asthmatics And COPD Drugs Market In 2023-Growth Strategies

30.3.1. Market Trend Based Strategies

30.3.2. Competitor Strategies

31. Global Anti-Asthmatics And COPD Drugs Market Recommendations

31.1. Conclusions

31.2. Recommendations

31.2.1. Product

31.2.2. Place

31.2.3. Price

31.2.4. Promotion

32. Appendix

32.1. Market Data Sources

32.2. Research Methodology

32.3. Currencies

32.4. Research Inquiries

32.5. The Business Research Company

32.6. Copyright and Disclaimer


List Of Figure

Figure 1: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Class

Figure 2: Global Anti-Asthmatics And COPD Drugs Market Segmentation By End User

Figure 3: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Distribution Channel

Figure 4: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Therapy

Figure 5: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Route Of Administration

Figure 6: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Age Group

Figure 7: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Prescription

Figure 8: Global Anti-Asthmatics And COPD Drugs Market Segmentation By Drug Type

Figure 9: Market Supply Chain For Anti-Asthmatics And COPD Drugs

Figure 10: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 11: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 12: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 13: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019

Figure 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019

Figure 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019

Figure 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019

Figure 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019

Figure 22: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 23: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 24: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 25: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 26: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 27: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 28: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 29: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 30: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 31: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 32: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 33: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 34: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 35: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 36: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 37: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 38: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 39: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 40: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 41: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 42: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 43: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 44: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 45: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 46: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 47: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 48: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 49: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 50: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 51: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 52: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 53: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 54: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 55: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 56: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 57: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 58: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 59: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 60: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 61: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 62: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 63: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 64: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 65: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 66: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 67: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 68: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 69: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 70: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 71: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 72: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 73: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 74: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 75: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 76: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 77: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 78: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 79: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 80: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 81: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 82: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 83: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 84: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 85: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 86: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 87: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 88: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 89: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 90: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 91: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 92: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 93: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 94: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Figure 95: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Figure 96: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 97: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Figure 98: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)

Figure 99: GlaxoSmithKline-Financial Performance, 2015-2019, USD Billion

Figure 100: AstraZeneca plc.-Financial Performance2015-2019, USD Billion

Figure 101: Boehringer Ingelheim GmbH-Financial Performance, 2015-2019, USD Billion

Figure 102: F. Hoffmann-La Roche Ltd-Financial Performance, 2015-2019, USD Billion

Figure 103: Novartis AG-Financial Performance, 2015-2019, USD Billion

Figure 104: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2023, USD Billion

Figure 105: Global Respiratory Diseases Drugs Market, 2019, Split By Region

Figure 106: Global Respiratory Diseases Drugs Market, 2015-2023, Historic And Forecast Growth Rate, Split By Region


List Of Table

Table 1: Global Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

Table 2: Global Anti-Asthmatics And COPD Drugs Market, Top 10 Drugs Sales, 2019

Table 3: Global Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs, 2019

Table 4: Anti-Asthmatics And COPD Drugs Market Regulatory Landscape

Table 5: Prevalence Of Asthma, 2014-2017

Table 6: Prevalence Of COPD, 2014-2017

Table 7: Global Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 8: Global Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 9: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 10: Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 11: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 12: Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 13: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 14: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 15: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 16: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 17: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 18: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 19: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2019

Table 20: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2019

Table 21: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2019

Table 22: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2019

Table 23: Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Drug, 2019

Table 24: Asia-Pacific Public Healthcare Expenditure, 2015-2019, USD Billion

Table 25: Asia-Pacific Private Healthcare Expenditure, 2015-2019, USD Billion

Table 26: Asia-Pacific Total Population Aged 65 And Above, 2015-2023, Thousands

Table 27: Air Pollution And Air Quality Index, Asia-Pacific Countries

Table 28: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 29: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 30: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 31: Asia Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 32: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 33: Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 34: China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 35: China Total Population Aged 65 And Above, 2015-2023, Thousands

Table 36: China Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 37: China Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 38: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 39: China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 40: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 41: China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 42: India Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 43: India Total Population Aged 65 And Above, 2015-2023, Thousands

Table 44: India Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 45: India Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 46: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 47: India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 48: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 49: India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 50: Japan Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 51: Japan Total Population Aged 65 And Above, 2015-2023, Thousands

Table 52: Japan Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 53: Japan Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 54: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 55: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 56: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 57: Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 58: Australia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 59: Australia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 60: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 61: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 62: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 63: Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 64: Indonesia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 65: Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 66: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 67: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 68: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 69: Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 70: South Korea Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 71: South Korea Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 72: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 73: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 74: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 75: South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 76: Western Europe Public Healthcare Expenditure, 2015-2019, USD Billion

Table 77: Western Europe Private Healthcare Expenditure, 2015-2019, USD Billion

Table 78: Western Europe Total Population Aged 65 And Above, 2015-2023, Thousands

Table 79: Air Pollution And Air Quality Index in 2018, Western Europe Countries

Table 80: Western Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 81: Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 82: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 83: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 84: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 85: Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 86: UK Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 87: UK Total Population Aged 65 And Above, 2015-2023, Thousands

Table 88: UK Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 89: UK Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 90: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 91: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 92: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 93: UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 94: Germany Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 95: Germany Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 96: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 97: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 98: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 99: Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 100: France Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 101: France Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 102: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 103: France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 104: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 105: France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 106: Eastern Europe Public Healthcare Expenditure, 2015-2019, USD Billion

Table 107: Eastern Europe Private Healthcare Expenditure, 2015-2019, USD Billion

Table 108: Eastern Europe Total Population Aged 65 And Above, 2015-2023, Thousands

Table 109: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 110: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 111: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 112: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 113: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 114: Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 115: Russia Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 116: Russia Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 117: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 118: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 119: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 120: Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 121: North America Public Healthcare Expenditure, 2015-2019, USD Billion

Table 122: North America Private Healthcare Expenditure, 2013-2017, USD Billion

Table 123: North America Total Population Aged 65 And Above, 2015-2023, Thousands

Table 124: North America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 125: North America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 126: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 127: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 128: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 129: North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 130: USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, USD Billion

Table 131: USA Total Population Aged 65 And Above, 2015-2023, Thousands

Table 132: USA Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 133: USA Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 134: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 135: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 136: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 137: USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 138: South America Public Healthcare Expenditure, 2015-2019, USD Billion

Table 139: South America Private Healthcare Expenditure, 2015-2019, USD Billion

Table 140: South America Total Population Aged 65 And Above, 2015-2023, Thousands

Table 141: South America Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 142: South America Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 143: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 144: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 145: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 146: South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 147: Brazil Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 148: Brazil Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 149: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 150: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 151: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 152: Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 153: Middle East Public Healthcare Expenditure, 2015-2019, USD Billion

Table 154: Middle East Private Healthcare Expenditure, 2015-2019, USD Billion

Table 155: Middle East Total Population Aged 65 And Above, 2015-2023, Thousands

Table 156: Middle East Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 157: Middle East Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 158: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 159: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 160: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 161: Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 162: Africa Public Healthcare Expenditure, 2015-2019, USD Billion

Table 163: Africa Private Healthcare Expenditure, 2015-2019, USD Billion

Table 164: Africa Total Population Aged 65 And Above, 2015-2023, Thousands

Table 165: Africa Anti-Asthmatics And COPD Drugs Market, Historic, 2015-2019, USD Million

Table 166: Africa Anti-Asthmatics And COPD Drugs Market, Forecast, 2019-2023, 2025F, 2030F, USD Million

Table 167: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 168: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 169: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, %

Table 170: Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Million

Table 171: Global Anti-Asthmatics And COPD Drugs Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)

Table 172: GlaxoSmithKline-Financial Performance, 2015-2019, USD Billion

Table 173: AstraZeneca plc.-Financial Performance2015-2019, USD Billion

Table 174: Boehringer Ingelheim GmbH-Financial Performance, 2015-2019, USD Billion

Table 175: F. Hoffmann-La Roche Ltd.-Financial Performance, 2015-2019, USD Billion

Table 176: Novartis AG-Financial Performance, 2015-2019, USD Billion

Table 177: Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2023, USD Billion

Table 178: Global Respiratory Diseases Drugs Market, 2019, Split By Region

Table 179: Global Respiratory Diseases Drugs Market, 2015-2023, Historic And Forecast Growth Rate, Split By Region

Table 180: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, By Country

Table 181: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, Segmentation By Drug Class

Table 182: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, By Type Of End User

Table 183: Anti-Asthmatics And COPD Drugs Market Size Gain (USD Million), 2019-2023, By Distribution Channel

Table 184: Anti-Asthmatics And COPD Drugs Market Data Sources

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

By Type Of Drug Class: Combination Drugs; Bronchodilators; Monoclonal Antibodies; Anti-Inflammatory Drugs By Type Of End-User: Asthma Patients; COPD Patients By Distribution Channel: General Pharmacies; Hospital Pharmacies; Online Retailers By Age Group: Below 5 Years; 5 to 14 Years; 15-69 Years; 70+ Years By Type Of Therapy: Preventive; Curative By Route Of Administration: Inhaled; Intravenous and Subcutaneous; Oral By Type Of Prescription: Prescription; OTC By Type Of Drug: Branded; Generics


Companies

GlaxoSmithKline plc.; AstraZeneca plc.; Boehringer Ingelheim; F. Hoffmann-La Roche Ltd; Novartis